Immediate and delayed hypersensitivity reactions to iodinated radiographic contrast agents: An update;Mise au point sur les réactions d'hypersensibilité immédiate et tardive aux produits de contraste iodés

Therapie

Volumn 64, Issue 5, 2009, Pages 331-339

  Khachman, Dalia ^a,b   Gandia, Peggy ^a,c   Sallerin, François ^d   Mailly, Nicolas ^d  

^a CHU PURPAN   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d Clinique d'Occitanie   (France)

Author keywords

Anaphylaxis; Delayed adverse reaction; Iodinated radiographic contrast agents; Premedication; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IODINATED CONTRAST MEDIUM;

ANAPHYLAXIS; ASTHMA; ATOPY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE;

EID: 73649120967     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie/2009040     Document Type: Article

References (108)

1. Coudert P, Rubat C, Chopineau J. Les produits de contraste iodés : caractéristiques physicochimiques. Actual Pharm 1999; 372: 17-19
2. Lavigne T, Imhoff O, Roedlich MN, et al. Utilisation des produits de contraste au cours des examens radiologiques réalisés en urgence : risques et précautions à prendre. Réanimation 2003; 12: 510-518
3. Dewachter P, Tréchot P, Mouton-Faivre C. " Allergie à l'iode " : le point sur la question. Rev Fr Allergol Immunol Clin 2005; 45: 476-488 (Pubitemid 41400238)
4. Lorusso V, Taroni P, Alvino S, et al. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. Invest Radiol 2001; 36: 309-316
5. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56(9): 813-824
6. Laxenaire MC, Mertes PM. Accidents anaphylactiques. EMC-Médecine 2004; 1: 59-69
7. Laxenaire MC. Le groupe d'études des réactions anaphylactoïdes peranesthésiques. Épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Réanim 1999; 18: 796-809
8. Sfar. Prévention du risque allergique peranesthésique. Recommandations pour la pratique clinique. Ann Fr Anesth Reanim 2002; 21(Suppl1): 1s-180s http://www.sfar.org/allergiefr.html
9. Cochran ST. Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep 2005; 5(1): 28-31
10. Lenler-Petersen P, Hansen D, Andersen M, et al. Drug related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the committee on adverse drug reactions. J Clin Epidemiol 1995; 48: 1185-1188
11. Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-846
12. Lapi F, Cecchi E, Pedone C, et al. Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol 2008; 64(7): 723-737
13. Christiansen C. X-ray contrast media. An overview. Toxicology 2005; 209(2): 185-187
14. Lieberman PL, Seigle RL. Reactions to radiocontrast material: anaphylactoid events in radiology. Clin Rev Allergy Immunol 1999; 17: 469-496
15. Dewachter P, Mouton-Faivre C. Réactions sévères avec les produits de contraste iodés : l'anaphylaxie est-elle responsable? J Radiol 2001; 82: 973-977
16. Dewachter P,Mouton-Faivre C, Felden F. Allergy and contrast media. Allergy 2001; 56: 250-251
17. Brockow K, Vieluf D, Püschel K, et al. Increased post-mortem serum mast cell tryptase in a fatal anaphylactoid reaction to non-ionic radiocontrast medium. J Allergy Clin Immunol 1999; 104: 237-238
18. Laxenaire MC, Torrens J, Moneret-Vautrin DA. Choc anaphylactoïde mortel chez un malade traité par â-bloquants. Ann Fr Anesth Reanim 1984; 3: 453-455
19. Witten DM, Hirsch FD, Hartman GW. Acute reactions to urographic contrast medium. AJR 1973; 119: 832-833
20. Ansell G, Tweedie MCK, West CR, et al. The current status of reactions to intravenous contrast media. Invest Radiol 1980; 15: S32-S38
21. Greenberger PA. Contrast media reactions. J Allergy Clin Immunol 1984; 74: 600-605
22. Shehadi WH. Contrast media adverse reactions: occurrence, recurrence and distribution patterns. Radiology 1982; 143: 11
23. Javeed N, Javeed H, Javeed S, et al. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 1996; 39: 383-384
24. Lang DM, Alpern MB, Visintainer PF, et al. Increased risk for anaphylactic reaction from contrast media in patients on betaadrenergic blockers or with asthma. Ann Intern Med 1991; 115: 270-276
25. Lang DM, Alpern MB, Visintainer PF, et al. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both betablocker exposure and cardiovascular disorders. Arch InternMed 1993; 153: 2033-2040
26. Cohan RH, Leder RA, Ellis JH. Treatment to adverse reaction to radiographic contrast media in adults. Radiol Clin North Am 1996; 34: 1055-1076
27. Lang DM, Alpern MB, Visintainer PF, et al. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol 1995; 95: 813-817
28. Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987; 317: 845-849
29. Toogood JH. Risk of anaphylaxis in patients receiving betablocker drugs. J Allergy Clin Immunol 1988; 81: 1-5
30. Kemp SF, Lieberman P. Inhibitors of angiotensin II: potential hazards for patients at risk for anaphylaxis. Ann Allergy Asthma Immunol 1997; 78: 527-529
31. Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994; 69(1): 16-23
32. Genovese A, Stellato C, Marsella C, et al. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int Arch Allergy Immunol 1996; 110: 13-22
33. Lasser E. Contrast media activation of serum complement system. Invest Radiol 1974; 9: 6
34. Lang J, Lasser E, Kolb W. Activation of serum complement by contrast media. Invest Radiol 1976; 11: 303-308
35. Heideman M, Jacobsson B, Lindhom N. Activation of the complement system by water-soluble contrast media. Acta Radiol Diagn 1976; 17: 733-736
36. Kolb W, Lang J, Lasser E. Nonimmunologic complement activation in normal human serum induced by radiographic contrast media. J Immunol 1978; 121: 1232-1238
37. Till G, Rother U, Diethard G. Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities. Int Arch Allergy Appl Immunol 1978; 56: 543-550
38. Hasselbacher P, Hahn J. In vitro effects of radiographic contrast media on the complement system. J Allergy Clin Immunol 1980; 66: 217-222
39. Freyria A, Pinet A, Belleville J, et al. Effects of five different contrast agents on serum complement and calcium levels after excretory urography. J Allergy Clin Immunol 1982; 69: 397-403
40. Stellato C, de Crescenzo G, Patella V, et al. Human basophil/mast cell releasability. Heterogeneity of the effects of contrast media on mediator release. J Allergy Clin Immunol 1996; 97: 838-850
41. Herd CM, Robertson AR, Frewin DB, et al. Adverse reactions during intravenous urography: are these due to histamine release? Br J Radiol 1988; 61: 5-11
42. Laroche D, Aimone-Gastin I, Dubois F, et al. Mechanisms of severe immediate reactions to iodinated contrast material. Radiology 1998; 209: 183-190 (Pubitemid 28464665)
43. Rodriguez R, Guéant J, Aimone-Gastin I, et al. Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathy. Am J Cardiol 2001; 88(2): 185-188
44. Kanny G, Maria Y, Mentre B, et al. Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgEmediated reaction. Allergol Immunol 1993; 25: 425-430
45. Mita H, Tadokoro K, Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998; 53: 1133-1140
46. Alvarez-Fernandez JA, Valero AM, Pulido Z, et al. Hypersensitivity reaction to ioversol. Allergy 2000; 55: 581-582
47. Valfrey J, Newinger G, Arbogast R, et al. Choc à l'ioxaglate (Hexabrix 320®) lors de coronarographies. À propos de deux cas. Rev Fr Allergol Immunol Clin 2002; 42: 157-162
48. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1(8009): 466-469
49. American Academy of Allergy and Immunology. The use of in vitro tests for IgE antibody in the specific diagnosis of IgE-mediated disorders and in the formulation of allergen immunotherapy. J Allergy Clin Immunol 1992; 90: 263-267
50. Bernady A, Taytard A, Tunon de Lara JM. IgE spécifiques et histaminolibération. Rev Fr Allergol Immunol 1996; 36: 884-888
51. Morcos SK, Bellin MF, Thomsen HS, et al. Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking. Eur J Radiol 2008; 66: 225-229
52. Morcos SK, Thomsen HS, Webb JAW. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001; 11: 1720-1728
53. Thomsen HS,Morcos SK. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reaction to contrast media. Acad Radiol 2002; 9(2): S433-S435
54. Crepea SB, Allanson JC, Delambre L. The failure of antihistaminic drugs to inhibit diodrast reactions. NY State J Med 1949; 49: 2556-2558
55. Finby N, Evans JA, Steinberg I. Reactions from intravenous organic iodide compounds: pretesting and prophylaxis. Radiology 1958; 71: 15-17
56. Taragin BH, Newhouse JH. Pretreatment of patients with asthma who are administered low-osmolar contrast material. Am J Roentgenol 2001; 177: 1211-1212
57. Tillie-Leblond I, Magnan A, Pauli G, et al. Asthma and allergy: short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the "Asthma-Allergy" association. Respir Med 2008; 102: 1483-1493
58. Vervloet D, Rancé F, Birnbaum J, et al. L'asthme représente-t-il un facteur de risque de l'anaphylaxie? Rev Mal Respir 2007; 24(7S): 27-33
59. Madowitz JS, Schweiger MJ. Severe anaphylactoid reaction to radiographic contrast media: recurrence despite premedication with diphenhydramine and prednisone. JAMA 1979; 241: 2813-2815
60. Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991; 87: 867-872
61. e journée normande d'anesthésie- réanimation, 2005 http:// www.chu-rouen.fr
62. Dewachter P, Mouton-Faivre C. Prévention des réactions sévères après injection de produits de contraste iodés : revue de la littérature. J Radiol 2003; 84: 535-544 (Pubitemid 36764601)
63. Moneret-Vautrin DA, Kanny G, Morisset M, et al. Réactions anaphylactoïdes et cutanées tardives aux produits de contraste iodés : état actuel de la question-évolution des idées. Rev Méd Interne 2001; 22: 969-977
64. Balestreri L,Morassut S. Chemioembolizzazione epatica in paziente allergico al mezzo di contrasto iodato: uso del Gd-DTPA. Radiol Med 1998; 98: 208-209
65. Desplas M. L'allergie à l'iode existe-t-elle? BIP 2005; 11(2): 8
66. Daunt N. Iodine allergy. Am J Roentgenol 1998; 171(2): 518-519
67. Redman HC. Dermatitis as a complication of lymphangiography. Radiology 1966; 86: 323-326
68. Panto PN, Devies P. Delayed reactions to urographic contrast media. Br J Radiol 1986; 59: 41-44
69. Webb JA, Stacul F, Thomsen HS, et al. Members of the contrast media safety committee of the European society of urogenital radiology. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003; 13: 181-184
70. Beyer-Enke S, Zeitler E. Late adverse reactions to non-ionic contrast media. A cohort analytic study. Eur Radiol 1993; 3: 237
71. Rydberg J, Charles J, Aspelin P. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic dimeric contrast medium. Acta Radiol 1998; 39: 219-222
72. Yasuda R, Munechika H. Delayed adverse reactions to non-ionic monomeric contrast-enhanced media. Invest Radiol 1998; 33: 1-5
73. Pedersen SH, Svaland MG, Reiss AL, et al. Late allergy like reactions following vascular administration of radiography contrast media. Acta Radiol 1998; 39: 344-348
74. Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001; 11: 1267-1275
75. Christiansen C. Late-onset allergy-like reactions to X-ray contrast media. Curr Opin Allergy Clin Immunol 2002; 2: 333-339
76. Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to Xray contrast media: mechanistic considerations. Eur Radiol 2000; 10: 1965-1975
77. Newman B. Delayed adverse reaction to nonionic contrast agents. Pediatr Radiol 2001; 31: 597-599
78. Watanabe H, Sueki H, Nakada T, et al.Multiple fixed drug eruption caused by iomeprol (Iomeront®), a non-ionic contrast medium. Dermatology 1999; 198: 291-294
79. Second Expert Meeting on Mechanism. Delayed allergy-like reactions to Xray contrast media. Eur Radiol 1996; 6: 1-24
80. Stellato C, Adkinson NF. Pathophysiology of contrast media anaphylactoid reactions: new perspectives on an old problem. Allergy 1998; 53: 1111-1113
81. Yoshikawa H. Late adverse reaction to non ionic contrast media. Radiology 1992; 183: 737-740
82. Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a non-ionic, radioopaque contrast medium. Allergy 1998; 53: 1221-1224
83. Schick E,Weber L, Gall H. Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid. Contact Dermatitis 1996; 35: 312
84. Gall H, Pillekamp H, Peter RU. Late-type allergy to the X-ray contrast medium Solutrast- (iopamidol). Contact Dermatitis 1999; 40: 248-250
85. Hosoya T, Yamaguchi K, Akutsu T, et al. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 2000; 18 (1): 39-45
86. Bigby M, Jick S, Jick H, et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15 438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256(24): 3358-3363
87. Choi CU, Rha S-W, Suh SY, et al. Extensive exfoliative dermatitis induced by non-ionic contrast medium Iodixanol (Visipaque-) used during percutaneous coronary intervention. Int J Cardiol 2008; 124: e25-e27
88. Kanny G, Hoen B,Marie B, et al. Delayed adverse reaction to sodium ioxaglic acid-meglumine. Eur J Dermatol 2001; 11: 134-137
89. Sedano E, Vega JM, Rebollo S, et al. Delayed exanthema to nonionic contrast medium. Allergy 2001; 56: 1015
90. Brockow K, Becker EW, Worret WI, et al. Late skin test reactions to radiocontrast medium. J Allergy Clin Immunol 1999; 104: 1107-1108
91. Brockow K, Kiehn M, Kleinheinz A, et al. Positive skin tests in late reactions to radiographic contrast media. Allergol Immunol 1999; 31: 49-51
92. Lee ML, Chiu IS. Toxic epidermal necrolysis incriminating iopamidol in a child after cardiac catheterization. Int J Cardiol 2002; 82: 95-97
93. Savill JS, Barrie R, Ghosh S, et al. Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med 1988; 64: 392-394
94. Munechika H, Hiramatsu Y, Kudo S, et al. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003; 13(1): 185-194
95. Higashi TS, Katayama M. The delayed adverse reactions of low osmolar contrast media. Nippon Igaku Hoshasen Gakkai Zasshi 1990; 50(11): 1359-1366
96. Munechika H, Hiramatsu M, Nakamura H, et al. Large-scale study of delayed adverse events to non-ionic contrast medium, iohexol: incidence and risk factors of adverse events following non-interventional radiography. Eur Radiol 1999; 9(S1): S440
97. Oi H, Yamazaki H, Matsushita M. Delayed vs immediate adverse reactions to ionic and non-ionic low-osmolality contrast media. Radiat Med 1997; 15(1): 23-27
98. Mikkonen R, Vehmas T, Granlund H, et al. Seasonal variation in the occurrence of late adverse skin reactions to iodine-based contrast media. Acta Radiol 2000; 41(4): 390-393
99. Mikkonen R, Kontkanen T, Kivisaari L. Acute and late adverse reactions to low-osmolal contrast media. Acta Radiol 1995; 36(1): 72-76
100. Bartolucci F, Cecarini M, Gabrielli G, et al. Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study. Radiol Med 2000; 100(4): 273-278
101. Goodfellow T, Holdstock GE, Brunton FJ, et al. Fatal acute vasculitis after high-dose urography with iohexol. Br J Radiol 1986; 59(702): 620-621
102. Reynolds NJ, Wallington TB, Burton JL. Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol. Br J Dermatol 1993; 129(1): 82-85
103. Shulman KL, Thompson JA, Benyunes MC, et al. Adverse reactions to intravenous contrast media in patients treated with interleukin-2. J Immunother Emphasis Tumor Immunol 1993; 13(3): 208-212
104. Fishman JE, Aberle DR, Moldawer NP, et al. Atypical contrast reactions associated with systemic interleukin-2 therapy. Am J Roentgenol 1991; 156(4): 833-834
105. Zukiwski AA, David CL, Coan J, et al. Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer 1990; 65(7): 1521-1524
106. Oldham RK, Brogley J, Braud E. Contrast medium "recalls" interleukin-2 toxicity. J Clin Oncol 1990; 8(5): 942-943
107. Choyke PL, Miller DL, Lotze MT, et al. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992; 183: 111-114
108. Ring J, Arroyave CM, Frizler MJ, et al. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 1978; 32(1): 105-118